Table 1.
Demographics and clinical characteristics of patients with coronavirus disease 2019 (COVID-19).
| Total (n = 220) | Mild/moderate (n = 110) | Severe/Critiacal (n = 110) | p value* | |
|---|---|---|---|---|
| Age mean±SE | 57.2 ± 1.5 | 64.5 ± 1.27 | 0.001 | |
| Sex | ||||
| Female | 80 (36.36%) | 60 (54.54%) | 20 (18.18%) | 0.071 |
| Male | 140 (63.3%) | 50 (45.5%) | 90 (81.8%) | 0.071 |
| Clinical manifestations | ||||
| Fever | 185 (84.0%) | 90 (81.8%) | 95 (86.36%) | 1 |
| Dry cough | 176 (80%) | 88 (59.9%) | 88 (71%) | 0.075 |
| Fatigue | 171 (77.7%) | 82 (56.6%) | 89 (73%) | 0.008 |
| Dyspnea | 108 (49.0%) | 47 (32.4%) | 99 (90.0%) | 0.008 |
| Nausea and vomiting | 88 (40%) | 41 (37.2%) | 47 (42.7%) | 0.360 |
| Myalgia | 57 (25.9%) | 22 (31.8%) | 35 (20%) | 0.271 |
| Anosmia | 31 (14.0%) | 15 (13.6%) | 16 (14.5%) | 0.614 |
| Headache | 29 (13.1%) | 14 (12.7%) | 15 (13.6%) | 0.627 |
| Chest pain | 25 (11.3%) | 9 (8.1%) | 16 (14.5%) | 0.087 |
| Pharyngalgia | 6 (2.7%) | 2 (1.81%) | 4 (3.6%) | 0.838 |
| Ausculattory findings | ||||
| Normal | 34 (15.4%) | 27 (24.5%) | 7 (6.36%) | 0.003 |
| Attenuated breathing sound | 152 (69%) | 73 (66.3%) | 79 (71.8%) | 0.032 |
| Sharpened respiratory sound | 26 (11.8%) | 15 (13.6%) | 11 (10%) | 0.870 |
| Audible cracks diffusely | 140 (63.6%) | 62 (56.3%) | 78 (70.9%) | 0.001 |
| Audible whistling | 5 (2.2%) | 2 (1.8%) | 3 (2.7%) | 0.848 |
| CXR findings | ||||
| Normal finding | 10 (4.5%) | 10 (9.0%) | 0 (0%) | 0.000 |
| Interstitial thickening | 42 (19.0%) | 42 (38.1%) | 0 (0%) | 0.000 |
| Focal consolidation | 57 (25.9%) | 57 (51.8%) | 0 (0%) | 0.000 |
| Multifocal consolidation | 60 (27.2%) | 1 (0.9%) | 59 (53.6%) | 0.000 |
| ARDS | 51 (23.1%) | 0 (0%) | 51 (46.36%) | 0.000 |
Data expressed as mean, standard error (SR), frequency (percentage).
*
P values indicate differences between mild/moderate and severe/critical.
P < 0.05 was considered statistically significant.